MeadowBrook Investment Advisors LLC Decreases Stock Position in Waters Co. (NYSE:WAT)

MeadowBrook Investment Advisors LLC lessened its stake in shares of Waters Co. (NYSE:WAT) by 4.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,355 shares of the medical instruments supplier’s stock after selling 59 shares during the period. MeadowBrook Investment Advisors LLC’s holdings in Waters were worth $503,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of WAT. Kennebec Savings Bank purchased a new stake in Waters in the third quarter worth $33,000. Ashton Thomas Securities LLC bought a new position in shares of Waters during the 3rd quarter worth $35,000. Fortitude Family Office LLC grew its position in shares of Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 66 shares in the last quarter. R Squared Ltd bought a new position in shares of Waters during the 4th quarter worth $63,000. Finally, Itau Unibanco Holding S.A. grew its position in shares of Waters by 63.2% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 72 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

WAT has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft raised their price objective on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Barclays raised Waters from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $360.00 to $415.00 in a report on Monday. Cfra set a $389.00 price target on Waters in a report on Thursday, October 17th. Stifel Nicolaus raised their price target on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Sanford C. Bernstein raised Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target for the company in a report on Friday, January 10th. Ten investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Waters presently has an average rating of “Hold” and a consensus price target of $388.64.

Waters Stock Performance

Shares of NYSE:WAT opened at $405.28 on Wednesday. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38. The business’s 50 day moving average price is $390.34 and its 200-day moving average price is $363.72. The firm has a market capitalization of $24.07 billion, a PE ratio of 38.67, a P/E/G ratio of 7.37 and a beta of 1.01. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.